Table 2.
Screening of diagnostic biomarkers in Cancer network viewer
| hsa05200 Pathways in cancer—Homo sapiens (Human (37) [Cancer network viewer] |
|
hsa:183 AGT; angiotensinogen hsa:207 AKT1; AKT serine/threonine kinase 1 hsa:208 AKT2; AKT serine/threonine kinase 2 hsa:572 BAD; BCL2 associated agonist of cell death hsa:598 BCL2L1; BCL2 like 1 hsa:841 CASP8; caspase 8 hsa:842 CASP9; caspase 9 hsa:894 CCND2; cyclin D2 hsa:898 CCNE1; cyclin E1 hsa:1026 CDKN1A; cyclin dependent kinase inhibitor 1A hsa:1027 CDKN1B; cyclin dependent kinase inhibitor 1B hsa:1499 CTNNB1; catenin beta 1 hsa:1869 E2F1; E2F transcription factor 1 hsa:1906 EDN1; endothelin 1 hsa:1910 EDNRB; endothelin receptor type B hsa:2113 ETS1; ETS proto-oncogene 1, transcription factor hsa:2308 FOXO1; forkhead box O1 hsa:2950 GSTP1; glutathione S-transferase pi 1 hsa:3091 HIF1A; hypoxia inducible factor 1 subunit alpha hsa:7184 HSP90B1; heat shock protein 90 beta family member 1 hsa:3458 IFNG; interferon gamma hsa:3596 IL13; interleukin 13 hsa:3565 IL4; interleukin 4 hsa:3725 JUN; Jun proto-oncogene, AP-1 transcription factor subunit hsa:3845 KRAS; KRAS proto-oncogene, GTPase hsa:5604 MAP2K1; mitogen-activated protein kinase kinase 1 hsa:4790 NFKB1; nuclear factor kappa B subunit 1 hsa:4792 NFKBIA; NFKB inhibitor alpha hsa:4843 NOS2; nitric oxide synthase 2 hsa:1728 NQO1; NAD(P)H quinone dehydrogenase 1 hsa:5155 PDGFB; platelet derived growth factor subunit B hsa:5337 PLD1; phospholipase D1 hsa:5338 PLD2; phospholipase D2 hsa:5371 PML; PML nuclear body scaffold hsa:5578 PRKCA; protein kinase C alpha hsa:5970 RELA; RELA proto-oncogene, NF-kB subunit hsa:7157 TP53; tumor protein p53 |
| hsa05200 Pathways in cancer—Homo sapiens (Human (54) [Cancer network viewer] |
|
hsa:183 AGT; angiotensinogen hsa:207 AKT1; AKT serine/threonine kinase 1 hsa:208 AKT2; AKT serine/threonine kinase 2 hsa:367 AR; androgen receptor hsa:572 BAD; BCL2 associated agonist of cell death hsa:581 BAX; BCL2 associated X, apoptosis regulator hsa:596 BCL2; BCL2 apoptosis regulator hsa:598 BCL2L1; BCL2 like 1 hsa:836 CASP3; caspase 3 hsa:840 CASP7; caspase 7 hsa:841 CASP8; caspase 8 hsa:842 CASP9; caspase 9 hsa:894 CCND2; cyclin D2 hsa:898 CCNE1; cyclin E1 hsa:1026 CDKN1A; cyclin dependent kinase inhibitor 1A hsa:1027 CDKN1B; cyclin dependent kinase inhibitor 1B hsa:1499 CTNNB1; catenin beta 1 hsa:3576 CXCL8; C-X-C motif chemokine ligand 8 hsa:1869 E2F1; E2F transcription factor 1 hsa:1906 EDN1; endothelin 1 hsa:1910 EDNRB; endothelin receptor type B hsa:1950 EGF; epidermal growth factor hsa:2099 ESR1; estrogen receptor 1 hsa:2113 ETS1; ETS proto-oncogene 1, transcription factor hsa:2353 FOS; Fos proto-oncogene, AP-1 transcription factor subunit hsa:2308 FOXO1; forkhead box O1 hsa:2950 GSTP1; glutathione S-transferase pi 1 hsa:3091 HIF1A; hypoxia inducible factor 1 subunit alpha hsa:3162 HMOX1; heme oxygenase 1 hsa:7184 HSP90B1; heat shock protein 90 beta family member 1 hsa:3458 IFNG; interferon gamma hsa:3596 IL13; interleukin 13 hsa:3565 IL4; interleukin 4 hsa:3569 IL6; interleukin 6 hsa:3725 JUN; Jun proto-oncogene, AP-1 transcription factor subunit hsa:3845 KRAS; KRAS proto-oncogene, GTPase hsa:5604 MAP2K1; mitogen-activated protein kinase kinase 1 hsa:5594 MAPK1; mitogen-activated protein kinase 1 hsa:5595 MAPK3; mitogen-activated protein kinase 3 hsa:4780 NFE2L2; nuclear factor, erythroid 2 like 2 hsa:4790 NFKB1; nuclear factor kappa B subunit 1 hsa:4792 NFKBIA; NFKB inhibitor alpha hsa:4843 NOS2; nitric oxide synthase 2 hsa:1728 NQO1; NAD(P)H quinone dehydrogenase 1 hsa:5155 PDGFB; platelet derived growth factor subunit B hsa:5337 PLD1; phospholipase D1 hsa:5338 PLD2; phospholipase D2 hsa:5371 PML; PML nuclear body scaffold hsa:5468 PPARG; peroxisome proliferator activated receptor gamma hsa:5578 PRKCA; protein kinase C alpha hsa:5743 PTGS2; prostaglandin-endoperoxide synthase 2 hsa:5970 RELA; RELA proto-oncogene, NF-kB subunit hsa:7040 TGFB1; transforming growth factor beta 1 hsa:7157 TP53; tumor protein p53 |